JP Morgan Day 2: Allergan and Alkermes rise on patents and pipelines
This article was originally published in Scrip
Executive Summary
Specialty pharmaceutical companies took center stage on the second day of the 32nd Annual JP Morgan Healthcare Conference in San Francisco on 14 January as Allergan and Alkermes each reached new stock price highs based on the increasing strength of their portfolios.